Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning
Shevanthi Nayagam(Imperial College London), Timothy B. Hallett(Imperial College London), Lance E. Rodewald, Mark Thursz(Imperial College Healthcare NHS Trust), Daniel Low‐Beer(World Health Organization), Yingpeng Qiu(National Health and Family Planning Commission), Nick Walsh(World Health Organization Regional Office for the Americas), Weiwei Hou(National Health and Family Planning Commission), Polin Chan(Western University), Joo H Chang(National Health and Family Planning Commission), Fabio Scano(World Health Organization), Elisa Sicuri(Barcelona Institute for Global Health), Lan Zhang(Lanzhou University Second Hospital), Hui Zhuang(Institute of Crop Sciences), Yu Wang(Hangzhou Hospital of Traditional Chinese Medicine), Lai Wei(Tongji University), Xiaochun Wang(Jiangsu University), Guomin Zhang(MIT University), Wang Ailing(National Center for Women and Children’s Health, China CDC), Kun Zhao(Vanderbilt University Medical Center), Bernhard Schwartländer(World Health Organization), Yue Xiao(National Health and Family Planning Commission), Binyan Sui(National Health and Family Planning Commission), Jidong Jia(National Clinical Research Center for Digestive Diseases)
Cited by 42
Related Papers
The Genome of the Sea Urchin <i>Strongylocentrotus purpuratus</i>
|Science|2006|1.2k
A Catalog of Reference Genomes from the Human Microbiome
|Science|2010|717
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530